


Searching News Database: REPEL-CV
HSMN NewsFeed - 9 Mar 2009
FDA Approves SyntheMed's REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
FDA Approves SyntheMed's REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
HSMN NewsFeed - 18 Jul 2008
SyntheMed Appoints Corinne Mundin as Director, International Market Development
SyntheMed Appoints Corinne Mundin as Director, International Market Development
HSMN NewsFeed - 20 Sep 2007
FDA Panel Recommends Approval of SyntheMed's REPEL-CV(R) Adhesion Barrier for Pediatric Patients
FDA Panel Recommends Approval of SyntheMed's REPEL-CV(R) Adhesion Barrier for Pediatric Patients
HSMN NewsFeed - 28 Mar 2007
FDA Accepts Synthemed's Pre-Market Approval (PMA) Application for REPEL-CV(R)
FDA Accepts Synthemed's Pre-Market Approval (PMA) Application for REPEL-CV(R)
HSMN NewsFeed - 6 Sep 2006
SyntheMed Announces Positive Pivotal Clinical Trial Results for REPEL-CV(R)
SyntheMed Announces Positive Pivotal Clinical Trial Results for REPEL-CV(R)
Additional items found! 8
Members Archive contains
8 additional stories matching:
REPEL-CV
(Password required)
REPEL-CV
(Password required)
